FOR US HEALTHCARE PROFESSIONALS ONLY
Important Safety Information
Prescribing Information
Medical Information Center
Access
Educational Resources
Important Safety Information
Prescribing Information
Medical Information Center
Access
Educational Resources
Medical Information Center
Access
Educational Resources
Medical Information Center
Access
Educational Resources
Home
Site map
Site map
Home
INVEGA SUSTENNA
®
Efficacy
Pivotal Studies
Comparative Efficacy Study
Recently Diagnosed Study
Earlier Use Analysis
Hospital Readmissions Analysis
Safety & Tolerability
Adverse Reactions
Weight Change Data
Extrapyramidal Symptoms Data
Lipids Data
Prolactin Data
Dosing
Initiation and Maintenance
Transitioning From Other Antipsychotics
Missed Doses and Special Populations
Pharmacokinetics
Administration
INVEGA SUSTENNA
®
Patient/Caregiver Site
Schizoaffective Disorder
Efficacy
Safety & Tolerability
Dosing
INVEGA TRINZA
®
Efficacy
Long-Term Maintenance Study
Noninferiority Study
Remission Study
Safety & Tolerability
Overall Safety
Metabolic Data
Extrapyramidal Symptoms Data
Prolactin Data
Dosing
Treatment Transition
Missed Doses
Use in Special Populations
Pharmacokinetics
Administration
INVEGA TRINZA
®
Patient/Caregiver Site
INVEGA HAFYERA
®
Efficacy
Safety & Tolerability
Overall Safety
Metabolic Data
Extrapyramidal Symptoms Data
Prolactin Data
Dosing
Treatment Transition
Missed Doses
Pharmacokinetics
Administration
INVEGA HAFYERA
®
Patient/Caregiver Site
Important Safety Information
INVEGA SUSTENNA
®
(paliperidone palmitate), INVEGA TRINZA
®
(paliperidone palmitate), INVEGA HAFYERA
®
(paliperidone palmitate)
INVEGA SUSTENNA
®
(paliperidone palmitate) for Schizoaffective Disorder
RISPERDAL CONSTA
®
(risperidone)
RISPERDAL
®
(risperidone)
INVEGA
®
(paliperidone)
Prescribing Information
Medical Information Center
Access
Access and Affordability
CoverMyMeds
®
Educational Resources
Talking Treatment Videos
Getting Started
Partnering with Patients
My First LAI
Meaningful Moments
Success Stories
Choices and Voices™ Patient Survey
Back to Top
